EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays

Katherine A Devitt, Teri Oldaker, Kalpesh Shah, Andrea Illingworth

Cytometry Part B: Clinical Cytometry · 2023-09 · 104 (5) · 374-391

DOI: 10.1002/cyto.b.22123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 03.05.2023. Verfasst von Katherine A Devitt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Hemoglobinuria, Paroxysmal, Leukemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the clinical laboratory, flow cytometry assays are critical to providing diagnostic and prognostic information to the treating clinicians. A validation or verification provides confidence that the assay will yield reliable results that can be trusted to make critical medical decisions. The following performance specifications should be included in a validation for laboratory developed tests as needed: accuracy (or trueness), precision (reproducibility and repeatability), detection capability, selectivity, reference range, and sample and reagent stability. We define these terms and present our approach to validation of several common flow cytometry assays, including examples of a leukemia/lymphoma assay and a paroxysmal nocturnal hemoglobinuria (PNH) assay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemoglobinuria, ParoxysmalLeukemiaHumansFlow CytometryErythrocytesReproducibility of Results

Stichwörter der Autor:innen

erythrocyteflow cytometryleukemialymphomastandardization

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.
  • Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
  • Oldaker Consulting, San Clemente, California, USA.
  • Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
  • Dahl-Chase Diagnostic Services, Bangor, Maine, USA.

Zitieren

APA

Devitt, K. A., Oldaker, T., Shah, K., & Illingworth, A. (2023). Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays. Cytometry Part B: Clinical Cytometry, 104(5), 374-391. https://doi.org/10.1002/cyto.b.22123

Vancouver

Devitt KA, Oldaker T, Shah K, Illingworth A. Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays. Cytometry Part B: Clinical Cytometry. 2023;104(5):374-391. doi:10.1002/cyto.b.22123

BibTeX
@article{Devitt2023,
  author = {Devitt, Katherine A and Oldaker, Teri and Shah, Kalpesh and Illingworth, Andrea},
  title = {Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2023},
  volume = {104},
  number = {5},
  pages = {374--391},
  doi = {10.1002/cyto.b.22123}
}
Kostenlos starten →